Aroa Biosurgery Ltd Capital Reinvestment Ratio

Latest as of September 2025: 0.12x

Aroa Biosurgery Ltd capital reinvestment ratio. Aroa Biosurgery Ltd (ARX) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow (AU$3.64 Million) in capital expenditures (AU$455.08K). Check how aggressively does Aroa Biosurgery Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.12x
Capex / Operating Cash Flow

Operating Cash Flow

AU$3.64 Million
AUD

Capital Expenditures

AU$455.08K
AUD

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Aroa Biosurgery Ltd (2020–2020)

Capital reinvestment ratio of Aroa Biosurgery Ltd from 2020 to 2020. This chart tracks Aroa Biosurgery Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Aroa Biosurgery Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Aroa Biosurgery Ltd Capital Reinvestment Ratio by Year (2020–2020)

Aroa Biosurgery Ltd capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see ARX operating cash flow.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2020 1.13x AU$1.58 Million AU$1.78 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow